Bureau Veritas SA (OTCMKTS:BVRDF – Get Free Report) was the target of a significant decline in short interest in the month of December. As of December 15th, there was short interest totalling 343,100 shares, a decline of 5.8% from the November 30th total of 364,100 shares. Based on an average daily trading volume, of 8,400 shares, the short-interest ratio is currently 40.8 days.
Bureau Veritas Stock Performance
Bureau Veritas stock opened at $30.70 on Wednesday. The firm’s fifty day moving average is $31.09 and its 200 day moving average is $30.05. Bureau Veritas has a 12-month low of $24.90 and a 12-month high of $32.15.
Analyst Ratings Changes
A number of analysts have weighed in on the company. JPMorgan Chase & Co. downgraded Bureau Veritas from an “overweight” rating to a “neutral” rating in a report on Wednesday, October 2nd. The Goldman Sachs Group upgraded Bureau Veritas to a “strong-buy” rating in a report on Tuesday, October 1st.
Bureau Veritas Company Profile
Bureau Veritas SA provides laboratory testing, inspection, and certification services. It operates through six segments: Marine & Offshore; Agri-Food & Commodities; Buildings & Infrastructure; Industry; Certification; and Consumer Products. The company engages in inspecting, analyzing, auditing, and certifying the products, assets, and management systems of its clients in relation to regulatory or self-imposed standards, as well as issues compliance reports.
See Also
- Five stocks we like better than Bureau Veritas
- 3 Warren Buffett Stocks to Buy Now
- 3 Stocks Helping to Bring AI to Healthcare
- What is the S&P/TSX Index?
- 3 Stocks Ringing in The New Year With Large Buyback Announcements
- What Are Some of the Best Large-Cap Stocks to Buy?
- Why 2024 Was Great for Stocks—and Why 2025 Could Be Even Better
Receive News & Ratings for Bureau Veritas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bureau Veritas and related companies with MarketBeat.com's FREE daily email newsletter.